Gut health brand Supergut has secured new capital from Full Frame Growth Partners, and brought in former president of Vital Proteins as CEO.

Altimmune is a late clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based ...

On Monday, the company reported a 3.2% increase in first-half net income to R2.39bn. Aspen Pharmacare’s profit climbed after ...

Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...

The specialty pharmacy business may be the most attractive part of Walgreens as rumors swirl the company will be taken over ...

Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

Semaglutide may help reduce alcohol cravings and intake, according to a clinical trial. Participants receiving the drug drank ...

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their ...

A study in The American Journal of Pathology reveals an unexpected discovery: mice lacking the CD44 protein remain lean even ...